Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-02

Clinical Trial Update: Evaluation of Tolerance and Quality of Life in Patients With Neuroendocrine Tumors Treated With Oral Anti-Tumor Drugs Within a Therapeutic Education Program

View source ↗

Summary

A clinical trial protocol evaluating tolerance and quality of life in neuroendocrine tumors patients treated with oral anti-tumor drugs within a therapeutic edu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Neuroendocrine (NE) Tumors, Oral Anti-Tumor Drugs | Status: NOT_YET_RECRUITING